Clinical Trial Update: Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating probiotic Lactobacillus GG for minimal hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Minimal Hepatic Encephalopathy

Drugs mentioned

• Lactobacillus rhamnosus GG (Lactobacillus rhamnosus GG)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Minimal Hepatic Encephalopathy | Phase 1 | Status: COMPLETED